Senior insider sale
Chief Commercial Officer at MADRIGAL PHARMACEUTICALS, INC. — senior position signals high conviction
$1.53M
2.87K shares
What this filing means
HUNTSMAN CAROLE plans to sell 2.87K shares of MADRIGAL PHARMACEUTICALS, INC. valued at approximately $1.53M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/26/2026ACC: 0001628280-26-003478
Officer· Chief Commercial Officer
Since Mar 2026
2.87K
Shares to sell
$1.53M
Approx. market value
340.00
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Restricted Stock Unit Grant
Vesting of Restricted Stock Units
1/23/2026
340.00Total acquired340.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/23/2026 | Restricted Stock Unit Grant Vesting of Restricted Stock Units | 340.00 | — |
| Total | 340.00 | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
570.00
Market value
$281.9K
1/26/2026
—Completed
Units to sell
1.06K
Market value
$590.4K
11/21/2025
—Completed
Units to sell
894.00
Market value
$492.6K
11/21/2025
Planned — Approximate Date
Nasdaq Stock MarketPlanned
Units to sell
340.00
Market value
$163.4K
1/26/2026
Total
Units
2.87K
Value
$1.53M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/26/2026 | 570.00 | $281.9K | — | Completed |
11/21/2025 | 1.06K | $590.4K | — | Completed |
11/21/2025 | 894.00 | $492.6K | — | Completed |
| Planned — Approximate Date | ||||
1/26/2026 | 340.00 | $163.4K | Nasdaq Stock Market | Planned |
| Total | 2.87K | $1.53M | ||